Clinical Research

Evolocumab reduces risk of major cardiac events in diabetic patients
Late-breaking data out of ACC.26 suggest a more aggressive treatment approach for these patients could be beneficial.
Heart Rhythm 2026 to feature late-breaking EP data, hands-on training and more
Heart Rhythm 2026 in Chicago will include a total of 18 late-breaking clinical trials—and that is just the beginning. The four-day event kicks off April 23.
Late-breaking PCI data challenge the 'time is muscle' paradigm
Gregg Stone, MD, spoke to Cardiovascular Business about the lessons he and his colleagues learned from the STEMI DTU trial.
Early SAVR in asymptomatic heart patients linked to long-term benefits
New 10-year data explored the impact of performing SAVR on asymptomatic patients with severe aortic stenosis.
New data point to LAAO as a safe alternative to long-term drug therapy
At the end of the day, one electrophysiologist explained, these decisions should still be made on a case-by-case basis.

Video of Howard Herrmann, MD, explaining the details of the SMART trial that looked at TAVR in small annulus and found self-expanding TAVR valves work better in these patients than balloon-expanding TAVR.

Cardiologist highlights key takeaways from SMART trial, which looked at TAVR in small annulus patients

Howard C. Herrmann, MD, principal investigator of the SMART trial, discussed his team's research on self-expanding vs. balloon-expandable TAVR valves in patients with small annuli.

Ultrasound-damaged organoids show how brain injury may progress into ALS

Seeking ways to protect the brain, the researchers found a gene called KNNJ2 that aids in muscle contraction and relaxation.

Ultrasound specialists update recommendations for endometriosis screening

The authors recommend tweaking pelvic ultrasound with new maneuvers that produce clearer images.

ACC.24, the annual meeting of the American College of Cardiology (ACC), kicked off on Saturday, April 6, with a series of late-breaking clinical trials focused on testing the safety and effectiveness of new treatment strategies.

Day 1 at ACC.24: Late-breakers examine potential new heart attack, heart failure treatments

ACC.24 in Atlanta began Saturday, April 6, with a series of late-breaking clinical trials exploring brand new treatment strategies.

Thickening of artery wall, reduced heart function linked to HIV

HIV carries a fourfold increase in risk of sudden cardiac death, even in asymptomatic patients.

Microwave ablation an effective, safer treatment for thyroid carcinoma, study finds

A comparative analysis against surgical resection found MWS had the same survival rate and caused fewer side effects.

On-pump vs. off-pump CABG: No difference in long-term mortality, meta-analysis confirms

Researchers explored data from nearly 70,000 patients, sharing their findings in the American Journal of Cardiology.

UC San Diego earns $6.7M NIH grant to develop noninvasive imaging to quantify immune cells in tumors

The TAM-Sense technique is currently in pre-clinical development, but it could be used to develop new treatments.

Clinical Research

Evolocumab reduces risk of major cardiac events in diabetic patients

Heart Rhythm 2026 to feature late-breaking EP data, hands-on training and more

Late-breaking PCI data challenge the 'time is muscle' paradigm

Early SAVR in asymptomatic heart patients linked to long-term benefits

New data point to LAAO as a safe alternative to long-term drug therapy

Evolocumab reduces risk of major cardiac events in diabetic patients